Analysis Of The Trastuzumab Biosimilar Market As Herceptin Exclusivity Nears An End
Fuld + Company
To expand on the Fuld + Company, Pharma Companies to Watch Report, Analyst Robert Browne drilled in on the Biosimilar Marketplace in […]
Robert Browne is an analyst in the Health + Life Science practice at Fuld + Company. As a recent graduate from Bowdoin College, where he majored in Neuroscience and minored in Music Theory and Composition, he brings an eclectic background to the team. During his time at Bowdoin, he worked as Lab Assistant in the Neuroscience department in school and earned his EMT license in the states of Maine and Massachusetts. He was also a member of the campus Middle Eastern Ensemble as well as part of student-led community outreach programs for supplemental education, hunger prevention, and elderly care. Robert enjoys watching his favorite soccer team Tottenham Hotspur play, listening to music, and hiking. He has three dogs at home – two golden retrievers and one boxer – and loves to take them on walks.